Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.3 USD | -0.35% | -2.13% | -8.56% |
May. 13 | Baxter International's Clinolipid Injection Approved for Expanded Use in US | MT |
May. 10 | TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.56% | 18.05B | |
-5.48% | 182B | |
+2.10% | 111B | |
-3.31% | 68.48B | |
+0.77% | 49.69B | |
+7.98% | 44.46B | |
+2.33% | 40.67B | |
+22.59% | 31.22B | |
+1.86% | 26.09B | |
+15.30% | 25.32B |
- Stock Market
- Equities
- BAX Stock
- News Baxter International Inc.
- Transcript : Baxter International Inc., Q4 2022 Earnings Call, Feb 09, 2023